Skip to main content
OpenTrials

Clinical trial condition

Urethral Cancer

Explore clinical trials studying Urethral Cancer. Study availability and eligibility vary by location and protocol.

34 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Urethral Cancer trial results

Completed

Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer

NCT00004223

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 76 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Bladder Cancer

NCT00003701

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States
  • Indiana University Hospitals Indianapolis, Indiana, United States
  • Hunterdon Regional Cancer Center Flemington, New Jersey, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract

NCT00006111

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Institut Sainte Catherine Avignon, France
  • Centre Oscar Lambret Lille, France
  • Centre Leon Berard Lyon, France
  • Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France
View Trial Details
Completed

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

NCT01191892

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations
  • Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom
  • Wales Cancer Trials Unit Cardiff, Wales, United Kingdom
  • Ayr Hospital Ayr, United Kingdom
  • Royal Bournemouth General Hospital Bournemouth, United Kingdom
View all 21 locations
View Trial Details
Completed

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

NCT01089088

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, Avon, United Kingdom
  • Castle Hill Hospital Cottingham, East Yorkshire, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, England, United Kingdom
  • Churchill Hospital Oxford, Oxfordshire, United Kingdom
View all 16 locations
View Trial Details
Completed

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

NCT00003175

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Porto Alegre Hospital Porto Alegre, Rio Grande do Sul, Brazil
  • Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
  • Mount Sinai Hospital - Toronto Toronto, Ontario, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
View all 62 locations
View Trial Details

Related conditions